Andrew Peele was appointed Group Executive for ANSTO Nuclear Science and Technology in July 2021 and was Director of the Australian Synchrotron from 2013 -2021. He is an adjunct Professor of Physics at La Trobe University.
Showing 61 - 80 of 91 results
Australian Centre for Neutron Scattering
The Australian Centre for Neutron Scattering (ACNS) is a major research facility for neutron science that comprises a suite of neutron instruments with a range of techniques for scientific investigations in physics, chemistry, materials science, medicine and environmental science among other fields.
Nuclear medicine production at ANSTO
Ongoing media statements relating to nuclear medicine production.
Synroc: Australian innovation increases technology readiness for waste treatment plant
Careers at ANSTO
ANSTO seeks candidates who are passionate about making a contribution to Australian society through supporting nuclear science and technology.
Leadership changes at ANSTO
This afternoon, the Chair of ANSTO, Dr Annabelle Bennett, wrote to all staff to let them know that CEO Dr Adi Paterson has decided to resign. She said the Board is deeply appreciative of the contributions Adi has made, including to the health, research and academic outputs of ANSTO during his tenure. Mr Shaun Jenkinson will continue as Acting CEO, while the Board undertakes a global search for a permanent CEO.
Role at ANSTO
Nuclear medicine congress
Congress marks watershed moment for nuclear medicine and ANSTO
Some of Sydney’s best science teachers meet its best science infrastructure
OPAL multi-purpose reactor
Australia’s Open Pool Australian Lightwater (OPAL) reactor is a state-of-the-art 20 megawatt multi-purpose reactor that uses low enriched uranium (LEU) fuel to achieve a range of activities to benefit human health, enable research to support a more sustainable environment and provide innovative solutions for industry.
Boost to bone hormones as researchers open new avenues of osteoporosis research
Scanners to go to a new home after a decade of excellence in preclinical imaging research
Following a decade of imaging to support research and clinical trials at ANSTO and the University of Sydney’s Brain and Mind Centre at Camperdown, two PET scanners have been transferred to the University of Wollongong.
OPAL reactor back in business
Medical Research Future Fund Grant targeting glioma with precision radiotherapy and biochemical dose amplification
ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program, administered by the Department of Health and Aged Care.
Celebrating our shining stars of science at the ANSTO Awards
ANSTO’s experts build new knowledge, drive innovation and support training and development for the safe management of Australia's radioactive waste
ANSTO has almost seventy years of experience in advancing an understanding of the management of spent nuclear fuel and delivering safe and reliable forms for radioactive waste.
Community FAQs
Frequently asked questions about ANSTO for the community.
Imaging technology has the ability to capture and display gamma radiation
A new imaging technology developed at ANSTO makes it possible to image, identify and locate gamma-ray radiation in a safe and timely manner.
Microfluidics: the next wave of disruptive technology in radiochemistry?
Understanding how ventilation might impact blood flow in ventilated preterm babies
Hudson Institute of Medical Research and Monash University researchers used synchrotron X-rays produce powerful visualisation of video of changes to blood flow to brain during ventilation in large preterm clinical models.